The Direct-To-Consumer (DTC) Genetic Testing Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2024-2033).

Learn More On The Direct-To-Consumer (DTC) Genetic Testing Market:
https://www.thebusinessresearchcompany.com/report/direct-to-consumer-dtc-genetic-testing-global-market-report

As per The Business Research Company's comprehensive analysis presented in the Direct-To-Consumer (DTC) Genetic Testing Global Market Report 2024, the landscape of the direct-to-consumer (DTC) genetic testing market has undergone a substantial evolution, experiencing exponential growth from $1.57 billion in 2024 to a projected $1.83 billion in the same year, exhibiting an impressive compound annual growth rate (CAGR) of 16.6%. This surge is primarily attributed to an escalating interest in ancestry and heritage exploration, the burgeoning influence of health and wellness trends, the efficacy of marketing and consumer education, the increasing importance placed on privacy and control over genetic data, and the enhanced affordability and accessibility of genetic testing services.

Anticipating a continuation of this momentum, the direct-to-consumer (DTC) genetic testing market is poised for significant expansion, reaching an estimated valuation of $3.32 billion by 2028, propelled by a projected CAGR of 16.1%. This forthcoming growth is underpinned by various factors, including the diversification and enrichment of test offerings, seamless integration with the realm of personalized medicine, strategic collaborations with health and wellness industries, noteworthy advancements in genetic research, and the pivotal support and regulations enacted by governing bodies. Key trends in this forecast period encompass an expansive array of test offerings and panels, educational initiatives tailored for consumers, meticulous adherence to regulatory compliance and oversight, groundbreaking genomic data research and contributions, as well as a concerted effort towards price reduction and heightened accessibility.

The rising prevalence of diseases and disorders with genetic transmission capabilities is expected to propel the growth of the direct-to-consumer (DTC) genetic testing market going forward. Genetic disorder refers to an illness caused by changes (mutation) in a person's DNA and it includes single-gene, multifactorial and chromosomal disorders. Direct-to-consumer genetic testing promotes awareness of various genetic disorders that helps in making predictions about health and provides personalized information about an individual’s health, disease risk, and other traits, thus, helps in taking effective health and lifestyle decisions to reduce the disease risk. For instance, according to MedlinePlus, a US-based online information service provided by the United States National Library of Medicine, in 2021, syndrome A is identified in about 1 in 200,000 Americans each year and currently around 100,000 kids suffer from syndrome B, whereas, it is estimated that nearly 12,000 people died globally from syndrome C in 2020 and approximately 1% of people in the United States develop disorder D during their lifetimes. Furthermore, in February 2022, according to the World Health Organization (WHO), a Switzerland-based agency of the United Nations responsible for international public health, birth abnormalities cause 240,000 new-borns to pass away in the first 28 days of life each year and an additional 170,000 children between the ages of 1 month and 5 years die as a result of birth abnormalities which includes heart defects, neural tube defects, and Down syndrome (a genetic disorder). Therefore, the rising prevalence of diseases and disorders with genetic transmission capabilities is driving the growth of the direct-to-consumer (DTC) genetic testing market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=8957&type=smp

The direct-to-consumer (DTC) genetic testing market covered in this report is segmented –
1) By Type: Carrier Testing, Predictive Testing, Ancestry And Relationship Testing, Nutrigenomic Testing, Other Types
2) By Sample: Saliva, Urine, Blood
3) By Technology: Single Nucleotide Polymorphism Chips, Whole Genome Sequencing, Targeted Analysis
4) By Business Model: Health Planning Model, Comprehensive Genome Tests Model, Medical Precision Tests Model, Restricted Trait Tests Mode
5) By End User: Laboratories, Blood Banks, Nursing Homes, Hospitals, Imaging Centers, Home Care, Cosmetics, Other End-User

In navigating this dynamic landscape, major players in the direct-to-consumer (DTC) genetic testing market are strategically engaging in collaborations to fortify their market standing. These alliances, particularly those incorporating technology-integrated genetic testing, not only foster innovation but also elevate diagnostic capabilities, extend global market reach, ensure meticulous adherence to regulatory standards, and propel advancements in personalized medicine. A noteworthy exemplar of such collaboration unfolded in June 2022, as Myriad Genetics, a distinguished US-based genomic testing company, and Epic Systems, a prominent US-based software company, joined forces to integrate electronic health records (EHR) with genetic testing. This collaborative effort streamlines the genetic testing process, empowering healthcare providers to seamlessly order and review Myriad tests within the Epic platform. The overarching goal is to elevate patient care by integrating critical genetic insights directly into the electronic health records (EHR) system. This strategic alignment with technology-enabled tools underscores Myriad's growth strategy, aiming to render genetic testing more accessible and efficient for both patients and clinicians alike.

The direct-to-consumer (dtc) genetic testing market report table of contents includes:
1. Executive Summary
2. Direct-To-Consumer (DTC) Genetic Testing Market Characteristics
3. Direct-To-Consumer (DTC) Genetic Testing Market Trends And Strategies
4. Direct-To-Consumer (DTC) Genetic Testing Market - Macro Economic Scenario
5. Global Direct-To-Consumer (DTC) Genetic Testing Market Size and Growth

.....

32. Global Direct-To-Consumer (DTC) Genetic Testing Market Competitive Benchmarking
33. Global Direct-To-Consumer (DTC) Genetic Testing Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Direct-To-Consumer (DTC) Genetic Testing Market
35. Direct-To-Consumer (DTC) Genetic Testing Market Future Outlook and Potential Analysis
36. Appendix

Related Reports:
https://topprnews.com/chemical-tanker-shipping-market-report/
https://topprnews.com/chemicals-market-report/
https://topprnews.com/chickenpox-vaccine-market-share/
https://goodprnews.com/chemical-tanker-shipping-market-report/
https://goodprnews.com/chemicals-market-report-share/
https://goodprnews.com/chickenpox-vaccine-market-share/

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model